Lee Flaherty counsels both publicly traded and privately held companies as well as private equity and venture capital firms in a variety of corporate and securities law matters, including mergers and acquisitions, SEC regulatory reporting and compliance, and corporate governance and corporate finance matters.
Lee works within a range of industries, with a particular focus in the medical device, pharmaceutical, real estate investment trust (REIT) and manufacturing industries.
Prior to joining Bass, Berry & Sims, Lee was an associate at Phelps Dunbar, practicing in the areas of business and finance. In addition to his legal background, Lee is also a Certified Public Accountant (Mississippi).
Tennessee Bar Association
The Mississippi Bar
The Alabama Bar
American Bar Association — Business Law Section, Committee on Mergers & Acquisitions
American Health Law Association (AHLA)
Representation of a founder owned WorkCompEDI and its affiliates, a leading EDI clearinghouse for the Property & Casualty market, in its sale to Data Dimensions, LLC, the leading provider of outsourced document handling and workflow solutions and portfolio company of Thompson Street Capital Partners. The merged companies will operate under the Data Dimensions brand and will leverage their respective strengths to become the premier technology services organization in the P&C industry.
Representation of the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible for the operational and strategic management of Chartwell to CarepathRx, a platform company formed by Nautic Partners that offers pharmacy solutions to patients undergoing complicated medication therapies. Nautic will manage the UPMC pharmacy moving forward. Terms of the transaction were not disclosed.
Representation of OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care, in its sale to Amerita, Inc., a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. Terms of the transaction were not disclosed.
Representation of HigherDOSE, a growth stage wellness product and services company, as outside general counsel. We advise the company on corporate entity structure; equity incentives; intellectual property protection; data privacy, including CCPA and GDPR compliance; FDA compliance; commercial contracts; waivers; product safety and advertising matters.
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Mississippi College Law Review — Associate Editor
Moot Court Board
Hearin Merit Scholar